We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
UK-Australia Regulatory Cooperation: Guidance on Veterinary Medicines Simultaneous Reviews published.
VMD response to concerns raised following media reports of serious adverse events in dogs given the vaccine containing four strains of Leptospira bacteria.
The Animal and Plant Health Agency (APHA) and the Veterinary Medicines Directorate (VMD) have lit up their headquarters in Weybridge, Surrey.
Ectoparasiticide veterinary medicinal products and reporting adverse events.
The VMD’s online services will be unavailable from 6:00am Saturday 18 November until 9:00am Sunday 19 November due to essential site maintenance.
Third Pharmaceuticals in the Environment (PiE) Group meeting continue discussions regarding imidacloprid and fipronil.
Sales of antibiotics for use in food-producing animals fell by 9% last year and have reduced by 59% since 2014.
First published during the 2022 to 2024 Sunak Conservative government
VICH consultation on the guideline relating to good manufacturing practice for active pharmaceutical ingredients used in veterinary medicinal products.
The VMD’s online services will be unavailable on 30 September due to essential site maintenance.
A consignment of inappropriately stored and expired medicines has been seized from Anglia Veterinary Services, Cambridgeshire.
Awareness and action regarding increase of suspected adverse event reports following use of intravenous co-amoxiclav (amoxicillin and clavulanic acid) products.
More information following our investigation into an increase of adverse event reports following the cascade use of intravenous co-amoxiclav (amoxicillin and clavulanic acid) products.
The VMD’s online services will be unavailable from 8:00am to 5:00pm on 16 September due to essential site maintenance.
Introducing our biennial satisfaction survey for MAHs, Manufacturers, and Wholesale Dealers.
Dr Jen Dow, the Cross-Defra AMR Coordinator, talks about progress of the development of the new UK Antimicrobial Resistance National Action Plan (AMR NAP).
Second Pharmaceuticals in the Environment (PiE) Group meeting held with continued focus on imidacloprid and fipronil.
For awareness and action regarding accidental ingestion of pergolide based products.
Details of permanent vacancies for Efficacy Assessors in the Pharmaceuticals section.
Product defect recall alert for Buprevet 0.3 mg/ml Solution for Injection for Dogs and Cats Vm 57446/4007 distributed by Virbac.
Register your interest and save the date for our Antiparasitic Resistance Research Symposium on 9 August 2023.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).